SEARCH

SEARCH BY CITATION

  • 1
    Rock, K. L. and Goldberg, A. L., Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 1999. 17: 739779.
  • 2
    Pieters, J., MHC class II-restricted antigen processing and presentation. Adv. Immunol. 2000. 75: 159208.
  • 3
    Rock, K. L., A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 1996. 17: 131137.
  • 4
    Sant, A. J., Endogenous antigen presentation by MHC class II molecules. Immunol. Res .1994. 13: 253267.
  • 5
    Lechler, R., Aichinger, G. and Lightstone, L., The endogenous pathway of MHC class II antigen presentation. Immunol. Rev. 1996. 151: 5179.
  • 6
    Klein, L. and Kyewski, B., Self-antigen presentation by thymic stromal cells: a subtle division of labor. Curr. Opin. Immunol. 2000. 12: 179186.
  • 7
    Newcomb, J. R. and Cresswell, P., Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated alpha beta dimers. J. Immunol .1993. 150: 499507.
  • 8
    Chicz, R. M., Urban, R. G., Gorga, J. C., Vignali, D. A., Lane, W. S. and Strominger, J. L., Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J. Exp. Med. 1993. 178: 2747.
  • 9
    Jacobson, S., Sekaly, R. P., Jacobson, C. L., McFarland, H. F. and Long, E. O., HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic T cells. J. Virol. 1989. 63: 17561762.
  • 10
    Oxenius, A., Bachmann, M. F., Ashton-Rickardt, P. G., Tonegawa, S., Zinkernagel, R. M. and Hengartner, H., Presentation of endogenous viral proteins in association with major histocompatibility complex class II: on the role of intracellular compartmentalization, invariant chain and the TAP transporter system. Eur. J. Immunol. 1995. 25: 34023411.
  • 11
    Malnati, M. S., Marti, M., LaVaute, T., Jaraquemada, D., Biddison, W., DeMars, R. and Long, E. O., Processing pathways for presentation of cytosolic antigen to MHC class II-restrictd T cells. Nature 1992. 357: 702704.
  • 12
    Fenteany, G., Standaert, R. F., Lane, W. S., Choi, S., Corey, E. J. and Schreiber, S. L., Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 1995. 268: 726731.
  • 13
    Geier, E., Pfeifer, G., Wilm, M., Lucchiari-Hartz, M., Baumeister, W., Eichmann, K. and Niedermann, G., A giant protease with potential to substitute for some functions of the proteasome. Science 1999. 283: 978981.
  • 14
    Bauer, D., and Tampe, R., Herpes viral proteins blocking the transporter associated with antigen processing TAP–from genes to function and structure. Curr. Top. Microbiol. Immunol .2002. 269: 8799.
  • 15
    Pinet, V., Vergelli, M., Martin, R., Bakke, O. and Long, E. O., Antigen presentation mediated by recycling of surface HLA-DR molecules. Nature 1995. 375: 603606.
  • 16
    Pelham, H. R., Multiple targets for brefeldin A. Cell 1991. 67: 449451.
  • 17
    Schroter, C. J., Braun, M., Englert, J., Beck, H., Schmid, H. and H. Kalbacher, H., A rapid method to separate endosomes from lysosomal contents using differential centrifugation and hypotonic lysis of lysosomes. J. Immunol. Methods 1999. 227: 161168.
  • 18
    Pertoft, H., Fractionation of cells and subcellular particles with Percoll. J. Biochem. Biophys. Methods 2000. 44: 130.
  • 19
    Seglen, P. O. and Bohley, P., Autophagy and other vacuolar protein degradation mechanisms. Experientia 1992. 48: 158172.
  • 20
    Klionsky, D. J. and Ohsumi, Y., Vacuolar import of proteins and organelles from the cytoplasm. Annu. Rev. Cell.Dev. Biol. 1999. 15: 132.
  • 21
    Seglen, P. O. and Gordon, P. B., 3-Methyladenine: specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc. Natl. Acad. Sci. USA 1982. 79: 18891892.
  • 22
    Blommaart, E. F., Krause, U., Schellens, J. P., Vreeling-Sindelarova, H. and Meijer, A. J., The phosphatidylinositol 3-kinase inhibitors wortmannin and LY294002 inhibit autophagy in isolated rat hepatocytes. Eur. J. Biochem. 1997. 243: 240246.
  • 23
    Dunn, W. A. Jr., Studies on the mechanisms of autophagy: maturation of the autophagic vacuole. J. Cell. Biol. 1990. 110: 19351945.
  • 24
    Codogno, P., Ogier-Denis, E. and Houri, J. J., Signal transduction pathways in macroautophagy. Cell Signal .1997. 9: 125130.
  • 25
    Brazil, M. I., Weiss, S. and Stockinger, B., Excessive degradation of intracellular protein in macrophages prevents presentation in the context of major histocompatibility complex class II molecules. Eur. J. Immunol. 1997. 27: 15061514.
  • 26
    Brooks, A. G. and McCluskey, J., Class II-restricted presentation of a hen egg lysozyme determinant derived from endogenousantigen sequestered in the cytoplasm or endoplasmic reticulum of the antigen presenting cells. J. Immunol. 1993. 150: 36903697.
  • 27
    Gueguen, M. and Long, E. O., Presentation of a cytosolic antigen by major histocompatibility complex class II molecules requires a long-lived form of the antigen. Proc. Natl. Acad. Sci. USA 1996. 93: 1469214697.
  • 28
    Dongre, A. R., Kovats, S., deRoos, P., McCormack, A. L., Nakagawa, T., Paharkova-Vatchkova, V., Eng, J., Caldwell, H., Yates III, J. R. and Rudensky, A. Y., In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses. Eur. J. Immunol. 2001. 31: 14851494.
  • 29
    Oukka, M., Colucci-Guyon, E., Tran, P. L., Cohen-Tannoudji, M., Babinet, C., Lotteau, V. and Kosmatopoulos, K., CD4 T cell tolerance to nuclear proteins induced by medullary thymic epithelium. Immunity 1996. 4: 545553.
  • 30
    Garrido, F. and Ruiz-Cabello, F., MHC expression on human tumors – its relevance for local tumor growth and metastasis. Semin. Cancer Biol. 1991. 2: 310.
  • 31
    Wang, R. F., The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity. Trends Immunol .2001. 22: 269276.
  • 32
    Simons, J. W., Jaffee, E. M., Weber, C. E., Levitsky, H. I., Nelson, W. G., Carducci, M. A., Lazenby, A. J., Cohen, L. K., Finn, C. C., Clift, S. M., Hauda, K. M., Beck, L. A., Leiferman, K. M., Owens Jr., A. H., Piantadosi, S., Dranoff, G., Mulligan, R. C., Pardoll, D. M. and Marshall, F. F., Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer. Cancer Res. 1997. 57: 15371546.
  • 33
    Visseren, M. J., van Elsas, A., van der Voort, E. I., Ressing, M. E., Kast, W. M., Schrier, P. I. and Melief, C. J., CTL specific for the tyrosinase autoantigen can be induced from healthy donor blood to lyse melanoma cells. J. Immunol. 1995. 154: 39913998.
  • 34
    Grignani, F., Kinsella, T., Mencarelli, A., Valtieri, M., Riganelli, D., Grignani, F., Lanfrancone, L., Peschle, C., Nolan, G. P. and Pelicci, P. G., High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein. Cancer Res. 1998. 58: 1419.
  • 35
    Gatfield, J., Lammert, E., Nickolaus, P., Munz, C., Rothenfusser, S., Fisch, P., Stevanovic, S., Schild, H., Rammensee, H. G. and Arnold, D., Cell lines transfected with the TAP inhibitor ICP47 allow testing peptide binding to a variety of HLA class I molecules. Int. Immunol. 1998. 10: 16651672.